Physician profile
Uma Mohan
NPI 1003916750
$997.93
in general payments reported to CMS, 2019-2025
12 companies · $77.12 in 2025
The $77.12 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.89 · 2020: $106 · 2021: $206 · 2022: $104 · 2023: $265 · 2024: $184 · 2025: $77.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $478.12 | 2019-2025 | Sutab, Suflave |
| Ironwood Pharmaceuticals, INC | $104.48 | 2021-2024 | Linzess |
| Celgene Corporation | $102.83 | 2023-2024 | Zeposia |
| Abbvie INC. | $81.31 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.10 | 2020-2024 | Gattex |
| Ferring Pharmaceuticals INC. | $45.52 | 2019 | |
| Redhill Biopharma INC. | $43.52 | 2022-2024 | Talicia |
| Capsovision, INC. | $31.37 | 2025 | Capsocam Plus |
| Nestle Healthcare Nutrition INC. | $26.19 | 2021-2023 | |
| Boston Scientific Corporation | $23.44 | 2023 | Resolution 360 Clip |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.05 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uma Mohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.